JWM
ABBV icon

JGP Wealth Management’s AbbVie ABBV Stock Holding History

JGP Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.31M Sell
17,144
-282
-2% -$60.7K 0.39% 48
2026
Q1 		$3.79M Buy
17,426
+459
+3% +$102K 0.39% 54
2025
Q4 		$3.88M Sell
16,967
-104
-0.6% -$23.7K 0.4% 51
2025
Q3 		$4.04M Sell
17,071
-510
-3% -$104K 0.45% 52
2025
Q2 		$3.26M Sell
17,581
-118
-0.7% -$21.9K 0.4% 54
2025
Q1 		$3.71M Sell
17,699
-218
-1% -$42.4K 0.49% 49
2024
Q4 		$3.18M Buy
17,917
+248
+1% +$45.6K 0.41% 51
2024
Q3 		$3.49M Sell
17,669
-217
-1% -$40.5K 0.45% 49
2024
Q2 		$3.07M Sell
17,886
-644
-3% -$107K 0.44% 51
2024
Q1 		$3.37M Sell
18,530
-790
-4% -$136K 0.49% 53
2023
Q4 		$2.99M Sell
19,320
-1,210
-6% -$176K 0.44% 49
2023
Q3 		$3.06M Buy
20,530
+57
+0.3% +$8.37K 0.51% 46
2023
Q2 		$2.76M Buy
20,473
+641
+3% +$94K 0.45% 50
2023
Q1 		$3.16M Buy
19,832
+541
+3% +$82.7K 0.55% 46
2022
Q4 		$3.12M Sell
19,291
-423
-2% -$64.9K 0.57% 45
2022
Q3 		$2.74M Buy
19,714
+587
+3% +$84.2K 0.58% 46
2022
Q2 		$2.92M Buy
19,127
+213
+1% +$32.5K 0.59% 46
2022
Q1 		$3.31M Sell
18,914
-1,284
-6% -$187K 0.61% 45
2021
Q4 		$2.74M Buy
20,198
+189
+0.9% +$22.3K 0.51% 46
2021
Q3 		$2.16M Buy
20,009
+337
+2% +$38.5K 0.47% 49
2021
Q2 		$2.22M Sell
19,672
-1,344
-6% -$151K 0.48% 50
2021
Q1 		$2.27M Sell
21,016
-376
-2% -$40.2K 0.51% 46
2020
Q4 		$2.32M Buy
21,392
+2,585
+14% +$248K 0.54% 46
2020
Q3 		$1.64M Sell
18,807
-37
-0.2% -$3.48K 0.44% 51
2020
Q2 		$1.87M Sell
18,844
-26
-0.1% -$2.29K 0.55% 47
2020
Q1 		$1.48M Buy
18,870
+1,020
+6% +$86.9K 0.53% 50
2019
Q4 		$1.6M Sell
17,850
-717
-4% -$59.5K 0.47% 55
2019
Q3 		$1.34M Buy
18,567
+232
+1% +$15.9K 0.46% 58
2019
Q2 		$1.33M Buy
18,335
+221
+1% +$17.4K 0.47% 58
2019
Q1 		$1.46M Buy
18,114
+1,163
+7% +$95.1K 0.55% 57
2018
Q4 		$1.56M Buy
16,951
+612
+4% +$53.8K 0.65% 54
2018
Q3 		$1.54M Sell
16,339
-513
-3% -$48.6K 0.62% 58
2018
Q2 		$1.56M Buy
+16,852
New +$1.65M 0.65% 59

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

JGP Wealth Management's ABBV Position: Q2 2026 in Review

JGP Wealth Management reduced its AbbVie (ABBV) stake by 1.6% in Q2 2026, selling an estimated $60.7K and leaving 17,144 shares worth $4.31M. The position accounts for 0.39% of the portfolio, ranked #48.

JGP Wealth Management first reported a position in ABBV in Q2 2018 and has held it in 33 quarters since. 1,602 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • JGP Wealth Management held 17,144 shares of AbbVie worth $4.31M as of Q2 2026.
  • JGP Wealth Management sold 282 AbbVie shares in Q2 2026, an estimated $60.7K.
  • AbbVie made up 0.39% of JGP Wealth Management's portfolio in Q2 2026, its #48 holding.
  • JGP Wealth Management first reported a position in AbbVie in Q2 2018 and has held it in 33 quarters since.
  • 1,602 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on JGP Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.